by Admin Neo Lumina | Nov 7, 2023 | News
Psychedelics Offer A New Mode Of Grief Therapy, But There’s A Catch Psychedelics are used to seek insight during life — and help people accept death. More and more families mourning the loss of a loved one are turning to psychedelic-assisted psychotherapy...
by Admin Neo Lumina | Nov 7, 2023 | News
Psilocybin for major depression trial shows positive results Cybin Inc. has announced Phase 2 interim results for CYB003 – its proprietary deuterated psilocybin analogue – which it says has demonstrated positive results with a rapid reduction in symptoms of major...
by Admin Neo Lumina | Nov 7, 2023 | News
Psilocin prodrug receives USPTO development approval Enveric Biosciences has received a Notice of Allowance (NoA) from the United States Patent and Trademark Office (USPTO) for a patent application involving EB-373, the company’s new chemical entity (NCE) prodrug of...
by Admin Neo Lumina | Nov 7, 2023 | News
Study to investigate psilocybin therapy for cancer-related depression Psychedelic therapy company Sunstone Therapies has announced the start of its first study investigating multiple doses of psilocybin in the treatment of major depression disorder (MDD) in patients...
by Admin Neo Lumina | Oct 25, 2023 | News
Psychedelic research receives Young Investigator Grants The Brain & Behavior Research Foundation has announced it is awarding $10.2 million in Young Investigator Grants including for projects investigating psychedelics. The grants have been awarded to 150...
by Admin Neo Lumina | Oct 25, 2023 | News
Nine ways to integrate the psychedelic experience for lasting change Following all the hype generated about the therapeutic powers of psychedelics by Michael Pollan’s 2018 book How to Change Your Mind and follow up 2022 Netflix series of the same title – millions are...
